Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.

被引：0
|
作者：
Wong, JB
Siebert, U
Manns, MP
McHutchison, JG
Sroczynski, G
Wasem, J
Ravens-Sieberer, U
Rossol, S
Ling, MH
Albrecht, JK
机构：
[1] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Hannover Med Sch, D-3000 Hannover, Germany
[4] Scripps Clin, La Jolla, CA USA
[5] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[6] Robert Koch Inst, D-1000 Berlin, Germany
[7] Univ Hosp, Mannheim, Germany
[8] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2075
引用
收藏
页码：691A / 691A
页数：1
相关论文
共 50 条
  • [1] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    [J]. HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [2] Cost-effectiveness of initial ribavirin interferon alfa-2B for chronic hepatitis C
    Wong, J
    McHutchinson, JG
    Poynard, T
    Ling, MH
    Albrecht, HK
    Pauker, SD
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A1289 - A1289
  • [3] Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.
    Wong, JB
    Davis, GL
    Pauker, SG
    [J]. HEPATOLOGY, 1998, 28 (04) : 591A - 591A
  • [4] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [5] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    [J]. World Journal of Hepatology, 2014, (07) : 520 - 526
  • [6] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [7] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [8] Impact of optimized treatment algorithms on the cost-effectiveness of ribavirin and peginterferon alfa-2B for chronic hepatitis C.
    Wong, JB
    McHutchison, JG
    Manns, MP
    Davis, GL
    Albrecht, JK
    [J]. HEPATOLOGY, 2002, 36 (04) : 717A - 717A
  • [9] Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden
    Sennfält, K
    Reichard, O
    Hultkrantz, R
    Wong, JB
    Jonsson, D
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 870 - 876
  • [10] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    [J]. HEPATOLOGY, 2003, 38 (04) : 629A - 629A
12345